Literature DB >> 15234959

Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.

Paolo Palange1, Gabriele Valli, Paolo Onorati, Rosa Antonucci, Patrizia Paoletti, Alessia Rosato, Felice Manfredi, Pietro Serra.   

Abstract

We tested the hypothesis that heliox breathing, by reducing lung dynamic hyperinflation (DH) and dyspnea (Dys) sensation, may significantly improve exercise endurance capacity in patients with chronic obstructive pulmonary disease [n = 12, forced expiratory volume in 1 s = 1.15 (SD 0.32) liters]. Each subject underwent two cycle ergometer high-intensity constant work rate exercises to exhaustion, one on room air and one on heliox (79% He-21% O2). Minute ventilation (VE), carbon dioxide output, heart rate, inspiratory capacity (IC), Dys, and arterial partial pressure of CO2 were measured. Exercise endurance time increased significantly with heliox [9.0 (SD 4.5) vs. 4.2 (SD 2.0) min; P < 0.001]. This was associated with a significant reduction in lung DH at isotime (Iso), as reflected by the increase in IC [1.97 (SD 0.40) vs. 1.77 (SD 0.41) liters; P < 0.001] and a decrease in Dys [6 (SD 1) vs. 8 (SD 1) score; P < 0.001]. Heliox induced a state of relative hyperventilation, as reflected by the increase in VE [38.3 (SD 7.7) vs. 35.5 (SD 8.8) l/min; P < 0.01] and VE/carbon dioxide output [36.3 (SD 6.0) vs. 33.9 (SD 5.6); P < 0.01] at peak exercise and by the reduction in arterial partial pressure of CO2 at Iso [44 (SD 6) vs. 48 (SD 6) Torr; P < 0.05] and at peak exercise [46 (SD 6) vs. 48 (SD 6) Torr; P < 0.05]. The reduction in Dys at Iso correlated significantly (R = -0.75; P < 0.01) with the increase in IC induced by heliox. The increment induced by heliox in exercise endurance time correlated significantly with resting increment in resting forced expiratory in 1 s (R = 0.88; P < 0.01), increase in IC at Iso (R = 0.70; P < 0.02), and reduction in Dys at Iso (R = -0.71; P < 0.01). In chronic obstructive pulmonary disease, heliox breathing improves high-intensity exercise endurance capacity by increasing maximal ventilatory capacity and by reducing lung DH and Dys.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234959     DOI: 10.1152/japplphysiol.01207.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  23 in total

1.  Combination therapy for exercise intolerance in COPD.

Authors:  R Casaburi
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

2.  Effects of a Highly Portable Noninvasive Open Ventilation System on Activities of Daily Living in Patients with COPD.

Authors:  Brian W Carlin; Kimberly S Wiles; Robert W McCoy; Toni Brennan; Dan Easley; Richard J Thomashow
Journal:  Chronic Obstr Pulm Dis       Date:  2015-01-01

3.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

4.  Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Gabriele Valli; Paolo Onorati; Patrizia Paoletti; Alessandro Maria Ferrazza; Paolo Palange
Journal:  Eur J Appl Physiol       Date:  2010-09-18       Impact factor: 3.078

5.  Air Current Applied to the Face Improves Exercise Performance in Patients with COPD.

Authors:  Nathaniel Marchetti; Matthew R Lammi; John M Travaline; David Ciccolella; Brian Civic; Gerard J Criner
Journal:  Lung       Date:  2015-08-09       Impact factor: 2.584

6.  Room air dilution of heliox given by facemask.

Authors:  Thomas D A Standley; Helen L Smith; Liam J Brennan; Ingrid A Wilkins; Peter G Bradley; Casiano Barrera Groba; Andrew J Davey; David K Menon; Daniel W Wheeler
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

Review 7.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

8.  Impaired exercise ventilatory mechanics with the self-contained breathing apparatus are improved with heliox.

Authors:  Scott J Butcher; Richard L Jones; Jonathan R Mayne; Timothy C Hartley; Stewart R Petersen
Journal:  Eur J Appl Physiol       Date:  2007-08-14       Impact factor: 3.078

Review 9.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.